| Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 182 | 2018 |
| Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia MO Nielsen, E Rostrup, S Wulff, N Bak, BV Broberg, H Lublin, S Kapur, ... Archives of general psychiatry 69 (12), 1195-1204, 2012 | 169 | 2012 |
| Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) A Egerton, BV Broberg, N Van Haren, K Merritt, GJ Barker, DJ Lythgoe, ... Molecular psychiatry 23 (11), 2145-2155, 2018 | 130 | 2018 |
| Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: a systematic review and individual participant data meta‐analysis D Siskind, M Hahn, CU Correll, A Fink‐Jensen, AW Russell, N Bak, ... Diabetes, Obesity and Metabolism 21 (2), 293-302, 2019 | 106 | 2019 |
| The Rho kinase inhibitor Fasudil up‐regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes CL Lau, RD O'shea, BV Broberg, L Bischof, PM Beart British journal of pharmacology 163 (3), 533-545, 2011 | 83 | 2011 |
| Evaluation of a neurodevelopmental model of schizophrenia—early postnatal PCP treatment in attentional set-shifting BV Broberg, R Dias, BY Glenthøj, CK Olsen Behavioural brain research 190 (1), 160-163, 2008 | 82 | 2008 |
| Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia—sub-chronic and early postnatal PCP treatment in attentional set … BV Broberg, BY Glenthøj, R Dias, DB Larsen, CK Olsen Psychopharmacology 206, 631-640, 2009 | 71 | 2009 |
| Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies—PSYSCAN: translating neuroimaging findings from research into clinical practice S Tognin, HH van Hell, K Merritt, I Winter-van Rossum, MG Bossong, ... Schizophrenia bulletin 46 (2), 432-441, 2020 | 70 | 2020 |
| Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial PL Ishøy, FK Knop, BV Broberg, N Bak, UB Andersen, NR Jørgensen, ... Diabetes, Obesity and Metabolism 19 (2), 162-171, 2017 | 67 | 2017 |
| Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: evidence for delayed up-regulation and redistribution of GLT-1 RD O'Shea, CL Lau, MC Farso, S Diwakarla, CJ Zagami, BB Svendsen, ... Neurochemistry international 48 (6-7), 604-610, 2006 | 67 | 2006 |
| Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis KB Bojesen, BH Ebdrup, K Jessen, A Sigvard, K Tangmose, RAE Edden, ... Psychological medicine 50 (13), 2182-2193, 2020 | 59 | 2020 |
| Differential expression of parvalbumin in neonatal phencyclidine‐treated rats and socially isolated rats SS Kaalund, J Riise, BV Broberg, K Fabricius, AS Karlsen, T Secher, ... Journal of neurochemistry 124 (4), 548-557, 2013 | 51 | 2013 |
| Associations between cognitive function and levels of glutamatergic metabolites and gamma-aminobutyric acid in antipsychotic-naïve patients with schizophrenia or psychosis KB Bojesen, BV Broberg, B Fagerlund, K Jessen, MB Thomas, A Sigvard, ... Biological psychiatry 89 (3), 278-287, 2021 | 49 | 2021 |
| Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies C Wenneberg, BY Glenthøj, C Hjorthøj, FJB Zingenberg, LB Glenthøj, ... Schizophrenia research 215, 38-48, 2020 | 46 | 2020 |
| No cognitive‐enhancing effect of GLP‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia PL Ishøy, B Fagerlund, BV Broberg, N Bak, FK Knop, BY Glenthøj, ... Acta Psychiatrica Scandinavica 136 (1), 52-62, 2017 | 36 | 2017 |
| Impaired GABAergic inhibition in the prefrontal cortex of early postnatal phencyclidine (PCP)-treated rats C Kjaerby, BV Broberg, U Kristiansen, NO Dalby Cerebral cortex 24 (9), 2522-2532, 2014 | 31 | 2014 |
| Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study CS Legind, BV Broberg, RCW Mandl, R Brouwer, SJ Anhøj, R Hilker, ... Neuropsychopharmacology 44 (3), 581-589, 2019 | 30 | 2019 |
| Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients D Nordholm, E Rostrup, V Mondelli, L Randers, MØ Nielsen, S Wulff, ... Psychoneuroendocrinology 92, 72-80, 2018 | 30 | 2018 |
| Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—gating of auditory-evoked potentials and prepulse inhibition BV Broberg, B Oranje, BY Glenthøj, K Fejgin, N Plath, JF Bastlund Behavioural brain research 213 (2), 142-147, 2010 | 30 | 2010 |
| Glutamate levels and resting cerebral blood flow in anterior cingulate cortex are associated at rest and immediately following infusion of S-ketamine in healthy volunteers KB Bojesen, KA Andersen, SN Rasmussen, L Baandrup, LM Madsen, ... Frontiers in Psychiatry 9, 22, 2018 | 27 | 2018 |
